Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients

This study aims to find out whether certain molecules in the blood, called microRNAs, are linked to how often and how severely people develop nerve damage from chemotherapy. The investigators will look at patients receiving cancer drugs known to affect the nerves, such as paclitaxel (used for lung cancer) and oxaliplatin (used for colorectal cancer).

NCT Number	NCT07427537
Lead Sponsor	University Hospital, Clermont-Ferrand
Conditions	Cancer, Lung, Colon Neoplasm, Neuropathy;Peripheral
Enrollment	90 participants
Start Date	2026-01-29
Primary Completion	2028-07-31 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-23